Dr. Byung Lee, DO

Dr. Lee practices at Hematology Oncology Specialists in Pasadena, California.

Dr. Lee's NPI, 1780975136, was assigned on April 20, 2011. Dr. Lee graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2005. Dr. Lee's California license number on file is 20A12262.

Dr. Lee's primary practice is Hematology Oncology Specialists, at 959 E Walnut St, Pasadena, CA 91106 in Los Angeles County. The practice phone is (323) 264-0430.

Dr. Lee's primary practice is Hematology Oncology Specialists in Pasadena, California. The medical group on file is Hematology Oncology Specialists. Dmand AI also links Dr. Lee to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lee is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 2 states: California and New York.

Dmand AI lists chronic anemia, deep vein thrombosis (DVT), lymphoma, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Lee treats.

CMS data shows 92 Medicare services from Dr. Lee across 2 procedure codes in 2024, for 59 Medicare patients. Medicare paid $5,880 for them. Every service was in an office.

CMS counts 59 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 28 patients. 71% of them have high blood pressure, and 64% have high cholesterol. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 72, with 62% women.

In 2024, Dr. Lee wrote 3,076 Medicare Part D claims for 539 patients. 59% of them were for generic drugs. CMS names the drug for 2,816 of them, across 46 drugs with 11 or more claims each, at $12,198,446 in total drug cost. In 2023, CMS named 2,836 claims across 45 drugs.

Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.

CMS Open Payments shows 1,314 general payments to Dr. Lee from 78 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,912.

Dr. Lee graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2005.

Dr. Lee is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.